Newsroom / Coronavirus

The latest product releases, company news and microsampling industry updates from neoteryx.

University of Rochester Examines Blood to Detect COVID-19 Antibodies

by Neoteryx, on April 27,2020

ROCHESTER, NY — Researchers around the globe are racing to respond to the COVID-19 pandemic. At the University of Rochester in the Clinical and Translational Science Institute (CTSI), researcher and …

Read Story

Topics:CoronavirusCOVID-19Viral Pathogens

NIH Begins Study to Quantify Undetected Cases of Coronavirus Infection

by Neoteryx, on April 10,2020

BETHESDA, MD — A new study has begun recruiting at the National Institutes of Health in Bethesda, Maryland to determine how many adults in the United States without a confirmed …

Read Story

Topics:CoronavirusCOVID-19Viral PathogensCoronavirus in the USNIH

The Mitra Microsampler class I medical device is for direct specimen collection and transportation of blood and other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA requirements. The Mitra Microsampling Device is a FDA listed Class 1 exempt device. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Newsroom / Coronavirus

University of Rochester Examines Blood to Detect COVID-19 Antibodies

NIH Begins Study to Quantify Undetected Cases of Coronavirus Infection

search our newsroom

news reporter resources:

social media

subscribe to news

Drop us a line

Neoteryx, LLC